InvestorsHub Logo
Followers 826
Posts 119438
Boards Moderated 16
Alias Born 09/05/2002

Re: None

Tuesday, 11/06/2018 9:29:43 AM

Tuesday, November 06, 2018 9:29:43 AM

Post# of 290
NKTR, PFE ink clinical-trial collaboration for NKTR-214 with PFE compounds:

https://finance.yahoo.com/news/clinical-oncology-collaboration-between-nektar-133000524.html

Under the new collaboration, Pfizer will initiate a Phase 1b/2 clinical trial to evaluate the anti-cancer activity of the combined agents, avelumab, talazoparib and NKTR-214 and separately avelumab, enzalutamide and NKTR-214. Nektar, Pfizer and their respective partners will each maintain global commercial rights to their respective medicines.

The indications to be tested include CRPC and SCCHN.

No cash is changing hands, apparently.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTR News